EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MCPIP1 Controls Hybrid EMT and Tumor Stemness via the IL6 / JAK2 / STAT3 Axis in Pancreatic Cancer

Xihui Ding iD, Yingying Zheng, Min Liu, Fu Lai, Shiqi Liu, Qiuping Chen, Zihao Zhu, Huanzhong Liu, Xiaohui Li, Jinyong Xu, Rui Wang, Zhenhua Ren iD

Cancer Medicine · 2025-09 · 14 (17)

DOI: 10.1002/cam4.71179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 28.08.2025. Verfasst von Xihui Ding und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, STAT3 Transcription Factor, Epithelial-Mesenchymal Transition, Interleukin-6. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, Major Projects of the Ministry of Science and Technology of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pancreatic cancer (PC) is a common malignant tumor with high morbidity and mortality and a very poor prognosis, highlighting the urgent need to identify molecular therapeutic targets. Monocyte chemotactic protein‐inducible protein‐1 (MCPIP1) is a common inflammatory protein associated with the pathogenesis of a variety of cancers, although a comprehensive understanding of its function and the underlying mechanisms involved in PC remains unclear. Materials and Methods Immunohistochemistry, western blotting, immunofluorescence, flow cytometry, Transwell, and the scratch assay were used to evaluate the functional role of MCPIP1 in PC. Human PC samples, PC cells, and tumor tissues from subcutaneous tumors of nude mice were examined for MCPIP1 and a panel of epithelial‐mesenchymal transition (EMT) ‐related indicators. In the mechanistic study, the IL6/JAK/STAT3 signaling pathway was investigated as a potential downstream pathway. IL6 activity was inhibited using the pharmacological inhibitor LMT‐28 and was applied to MCPIP1 gene‐deficient cells to assess the reversal of the malignant phenotype.

Results

MCPIP1 was significantly downregulated in PC tissues and its expression strongly correlated with patient survival. MCPIP1 knockdown enhanced tumor cell stemness, proliferation, migration, and hybrid epithelial‐mesenchymal transition (hybrid EMT) in PC cell lines, whereas overexpression suppressed these phenotypes. In xenograft models, MCPIP1 knockdown promoted tumor growth and hybrid EMT progression in mice. MCPIP1 knockdown activated the IL6/JAK/STAT3 signaling pathway, which was inhibited by MCPIP1 overexpression. LMT‐28 treatment reversed the stemness and hybrid EMT phenotypes of MCPIP1‐deficient cells.

Conclusion

MCPIP1 is a key regulator of PC progression, acting as a tumor suppressor by inhibiting the IL6/JAK/STAT3 signaling pathway. The findings suggest that MCPIP1 is a promising therapeutic target with potential implications for the development of new strategies for managing PC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsSTAT3 Transcription FactorEpithelial-Mesenchymal TransitionInterleukin-6RibonucleasesNeoplastic Stem CellsJanus Kinase 2Transcription FactorsHumansAnimalsMiceSignal TransductionCell Line, TumorMice, NudeMaleCell ProliferationFemaleGene Expression Regulation, NeoplasticCell MovementXenograft Model Antitumor Assays

Stichwörter der Autor:innen

IL6/JAK/STAT3 axishybrid epithelial‐mesenchymal transitionmonocyte chemotactic protein‐inducible protein‐1pancreatic cancertumor stemness

Substanzen

STAT3 Transcription FactorInterleukin-6ZC3H12A protein, humanRibonucleasesSTAT3 protein, humanJanus Kinase 2Transcription FactorsJAK2 protein, humanIL6 protein, human

Autor:innen und Institutionen

  • Department of Anatomy, Anhui Medical University, Hefei, Anhui, China.
  • Second Clinical Medical College, Anhui Medical University, Hefei, Anhui, China.
  • Department of Psychiatry, Chaohu Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Anhui Provincial Key Laboratory for Brain Bank Construction and Resource Utilization, Hefei, Anhui, China.

ORCID-Profile: Xihui Ding, Zhenhua Ren

Förderung

  • the National Natural Science Foundation of China
  • Major Projects of the Ministry of Science and Technology of China
  • National Natural Science Foundation of China

Zitieren

APA

Ding, X., Zheng, Y., Liu, M., Lai, F., Liu, S., Chen, Q., Zhu, Z., Liu, H., Li, X., Xu, J., Wang, R., & Ren, Z. (2025). MCPIP1 Controls Hybrid EMT and Tumor Stemness via the IL6 / JAK2 / STAT3 Axis in Pancreatic Cancer. Cancer Medicine, 14(17). https://doi.org/10.1002/cam4.71179

Vancouver

Ding X, Zheng Y, Liu M, Lai F, Liu S, Chen Q, et al. MCPIP1 Controls Hybrid EMT and Tumor Stemness via the IL6 / JAK2 / STAT3 Axis in Pancreatic Cancer. Cancer Medicine. 2025;14(17). doi:10.1002/cam4.71179

BibTeX
@article{Ding2025,
  author = {Ding, Xihui and Zheng, Yingying and Liu, Min and Lai, Fu and Liu, Shiqi and Chen, Qiuping and Zhu, Zihao and Liu, Huanzhong and Li, Xiaohui and Xu, Jinyong and Wang, Rui and Ren, Zhenhua},
  title = {MCPIP1 Controls Hybrid EMT and Tumor Stemness via the IL6 / JAK2 / STAT3 Axis in Pancreatic Cancer},
  journal = {Cancer Medicine},
  year = {2025},
  volume = {14},
  number = {17},
  doi = {10.1002/cam4.71179}
}
Kostenlos starten →